Compare Immunovant Inc. Common Stock (IMVT) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Immunovant Inc. Common Stock trades at $30.38 (market cap $6.25B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.76 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 7.4× Immunovant Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| IMVT | VMRK | |
|---|---|---|
Market Cap | $6.25B | $46.41B |
Volume | 1,755,411 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $44.96 | $70.15 |
52-Week Low | $17.03 | $57.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $55.52B |
Dividend Yield | — | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
